The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...

MAPS encourages other organizations and advocates to advocate for fair and effective drug policies that prioritize harm reduction, rehabilitation, and community well-being by using its template ...

MAPS encourages other organizations and advocates to advocate for fair and effective drug policies that prioritize harm reduction, rehabilitation, and community well-being by using its template ...

MAPS encourages other organizations and advocates to advocate for fair and effective drug policies that prioritize harm reduction, rehabilitation, and community well-being by using its template ...

"We remain on track to complete enrollment in both trials this year and are simultaneously engaging the U.S. Food & Drug Administration to define the optimal pivotal trial pathway." Additional ...

A recent analysis of drug prices, based on data provided by SaveHealth, highlights the severity of the issue and underscores the importance of prescription coupons in reducing costs. This stark ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn’t stopped the pharmaceutical company from preparing for its launch.

Kennedy Jr. assured a U.S. senator that he would not alter the country's vaccination schedule. However ... That is going to be our template. That's something that will make us all proud of this agency ...